Oribiotech secures major partnership to deploy IRO automated cell therapy manufacturing solution for commercial CAR-T product - validates AdAlta's selection of this platformLikeFollowSharehttps://oribiotech.com/press-releases/ori-biotech-announces-10-year-120m-partnership-to-advance-automated-manufacturing-for-commercial-cell-therapies Share your feedbackQuestions (0)Post questionYour question will be visible to everyone.Start the conversationAsk AdAlta a question about this update.Discover
